cabozantinib s malate

Drug Overview

Cabozantinib s-malate is an advanced, highly effective cancer medicine. It belongs to a modern family of cancer treatments known as Targeted Therapies or “Smart Drugs.” Unlike older chemotherapy drugs that attack all fast-growing cells in the body, targeted therapies act like homing missiles. They are designed to seek out and block specific signals that cancer cells use to grow, spread, and survive.

Because it targets multiple pathways at once, cabozantinib s-malate has become an essential treatment for several types of hard-to-treat cancers, giving patients new hope when other treatments have stopped working.

• Generic Name: Cabozantinib s-malate
• US Brand Names: CABOMETYX® (tablets) and COMETRIQ® (capsules). Note: These two brands are not interchangeable and are used for different types of cancer.
• Drug Class: Tyrosine Kinase Inhibitor (TKI) / Targeted Therapy
• Route of Administration: Oral (taken by mouth)
• FDA Approval Status: Fully FDA Approved

What Is It and How Does It Work? (Mechanism of Action)

Cabozantinib is a Targeted Therapy known as a multiple receptor tyrosine kinase inhibitor. To understand how it works, imagine a cancer cell as a factory that needs two things to thrive: a constant supply of fuel (blood) and a communication system telling it to keep building more factories.

At the molecular level, cabozantinib blocks several specific “communication antennas” (receptors) on the surface of cells. The most important ones it targets are:

1. VEGFR (Vascular Endothelial Growth Factor Receptors): Tumors need to build their own blood vessels to get oxygen and nutrients—a process called angiogenesis. Cabozantinib blocks VEGFR, effectively cutting off the tumor’s blood and food supply, causing it to starve.
2. MET and AXL: These are special receptors that cancer cells use to survive, resist medications, and spread (metastasize) to other parts of the body like the bones.
3. RET: A specific gene mutation that drives certain thyroid cancers.

By plugging into these receptors, cabozantinib turns the switches to the “OFF” position. This multi-targeted approach not only starves the tumor but also prevents the cancer cells from communicating, migrating, and growing, which eventually causes the cancer cells to die.

FDA Approved Clinical Indications

Oncological Uses

• Advanced Renal Cell Carcinoma (RCC): Used to treat advanced kidney cancer, either alone or in combination with the immunotherapy drug nivolumab.
• Hepatocellular Carcinoma (HCC): Used to treat liver cancer in patients who have previously been treated with the drug sorafenib.
• Differentiated Thyroid Cancer (DTC): Used for advanced thyroid cancer that has progressed after prior therapy and no longer responds to radioactive iodine treatment (using Cabometyx).
• Medullary Thyroid Cancer (MTC): Used for progressive, metastatic medullary thyroid cancer (using Cometriq).

Non-Oncological Uses

• There are no FDA-approved non-oncological uses for this medication. It is strictly used for the treatment of cancer.

Dosage and Administration Protocols

Because there are two different brand names for cabozantinib s-malate (Cabometyx and Cometriq), the dosages are very different. They cannot be substituted for one another. The medicine must be taken on an empty stomach (do not eat for at least 2 hours before and 1 hour after taking it).

Dose Adjustments for Organ Insufficiency

• Hepatic (Liver) Insufficiency: Because this drug is processed by the liver, patients with mild to moderate liver disease will need a reduced dose (e.g., lowering Cabometyx from 60 mg to 40 mg). It is not recommended for patients with severe liver disease.
• Renal (Kidney) Insufficiency: No dose adjustment is usually needed for mild or moderate kidney problems, but it should be used with extreme caution in patients with severe kidney disease.

Clinical Efficacy and Research Results

Recent clinical data (2020-2025) highlights cabozantinib as a highly effective therapy, especially when combined with other modern treatments.

• Kidney Cancer Success: In the landmark CheckMate 9ER trial, combining cabozantinib with the immunotherapy drug nivolumab doubled the progression-free survival (the time the cancer stopped growing) to an average of 16.6 months, compared to 8.3 months with older standard drugs. It also significantly improved overall survival rates.
• Thyroid Cancer Breakthrough: In the 2021 COSMIC-311 trial for radioactive iodine-refractory thyroid cancer, cabozantinib dramatically reduced the risk of the disease progressing or causing death by 78% compared to a placebo.
• Liver Cancer: The CELESTIAL trial proved that cabozantinib significantly extends the lives of patients with advanced liver cancer who have run out of other treatment options.

Safety Profile and Side Effects

Because cabozantinib affects blood vessels and cell growth, it can cause significant side effects. Patients are monitored very closely during treatment.

BLACK BOX WARNING: Severe Bleeding and Gastrointestinal Tears

The FDA has issued a strict warning for cabozantinib (especially Cometriq) because it can cause severe, sometimes fatal, bleeding (hemorrhage). It can also cause holes (perforations) or abnormal connections (fistulas) to form in the stomach or intestines. Patients with recent severe bleeding should not take this drug.

Common Side Effects (>10%)

• Diarrhea: This is very common and can be severe.
• Hand-Foot Syndrome: Redness, swelling, peeling, or pain on the palms of the hands and soles of the feet.
• Hypertension: High blood pressure.
• Fatigue: Feeling unusually tired or weak.
• Decreased Appetite and Weight Loss
• Nausea and Vomiting

Serious Adverse Events

• Severe Bleeding: Coughing up blood, blood in the stool, or severe internal bleeding.
• Thrombotic Events: Blood clots leading to heart attacks or strokes.
• Wound Healing Complications: The drug stops new blood vessels from forming, making it very hard for the body to heal from cuts or surgeries.
• Osteonecrosis of the Jaw (ONJ): Severe damage to the jawbone, often following dental work.

Management Strategies

• For High Blood Pressure: Your doctor will likely prescribe blood pressure medication to keep your numbers in a safe range.
• For Diarrhea: Keep over-the-counter anti-diarrhea medicines (like loperamide) at home and drink plenty of clear fluids.
• For Hand-Foot Syndrome: Use thick, urea-based moisturizing creams daily and wear thick cotton socks to protect your feet.

Connection to Immunotherapy and Research Areas

Cabozantinib is currently a massive focus in Immunotherapy research. While it directly kills cancer cells by starving them of blood, scientists recently discovered that it also changes the environment around the tumor. Tumors usually build a chemical “force field” that puts the patient’s immune system to sleep. Cabozantinib helps break down this force field. By reducing the number of “bad” immune cells that protect the tumor, cabozantinib paves the way for modern immunotherapy drugs (like nivolumab or pembrolizumab) to rush in and allow the body’s natural T-cells to destroy the cancer. This “Smart Drug” plus Immunotherapy combination is now a standard of care for advanced kidney cancer.

Patient Management and Practical Recommendations

Pre-Treatment Tests to be Performed

Before starting cabozantinib, your healthcare team will perform several checks:

• Blood Pressure Check: To ensure your blood pressure is well-controlled.
• Comprehensive Blood Work: Including liver function tests, kidney tests, and a thyroid panel.
• Dental Exam: A full dental checkup is required to fix any cavities or teeth issues before starting the drug to prevent jawbone damage.
• Pregnancy Test: For women of childbearing age, as the drug can harm an unborn baby.

Precautions During Treatment

• Surgery Warning: You must stop taking cabozantinib at least 3 to 4 weeks before any planned surgery (including dental surgery) because it stops wounds from healing properly.
• Check Your Blood Pressure: Monitor your blood pressure at home regularly and log the numbers for your doctor.

Do’s and Don’ts

• DO take the pill on an empty stomach. Do not eat anything for at least 2 hours before and 1 hour after your dose.
• DO swallow the tablets or capsules whole with a full glass of water. Do not crush, chew, or open them.
• DO tell your doctor immediately if you experience severe stomach pain, vomit blood, or see dark, tarry stools.
• DON’T eat grapefruit or drink grapefruit juice, as it can dangerously increase the amount of drug in your blood.
• DON’T take over-the-counter pain medicines like ibuprofen (Advil) or naproxen (Aleve) without asking your doctor, as they can increase your risk of bleeding.

Legal Disclaimer

The information provided in this guide is for educational and informational purposes only and does not constitute medical advice. Treatment protocols, dosages, and side effects vary by individual and by specific medical conditions. Patients should always consult with their primary oncologist or a qualified healthcare professional regarding diagnosis, treatment options, and the management of medical conditions. Do not disregard professional medical advice or delay in seeking it because of something you have read in this material.